TGFB1 and pulmonary fibrosis: It significantly suppressed the abnormal increase of interleukin-4 (IL-4) and TNF-α levels, increased the level of interferon-γ (IFN-γ), and contributed to the antifibrotic effects on pulmonary fibrosis by inhibiting TGF-β1 production in the lung [39].